BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arjonen A, Mäkelä R, Härmä V, Rintanen N, Kuopio T, Kononen J, Rantala JK. Image-based ex vivo drug screen to assess targeted therapies in recurrent thymoma. Lung Cancer 2020;145:27-32. [DOI: 10.1016/j.lungcan.2020.04.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Routila J, Qiao X, Weltner J, Rantala JK, Carpén T, Hagström J, Mäkitie A, Leivo I, Ruuskanen M, Söderlund J, Rintala M, Hietanen S, Irjala H, Minn H, Westermarck J, Ventelä S. Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma. Oral Oncol 2022;127:105772. [PMID: 35245886 DOI: 10.1016/j.oraloncology.2022.105772] [Reference Citation Analysis]
2 Nykänen N, Mäkelä R, Arjonen A, Härmä V, Lewandowski L, Snowden E, Blaesius R, Jantunen I, Kuopio T, Kononen J, Rantala JK. Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma. Front Oncol 2021;11:735820. [PMID: 34604070 DOI: 10.3389/fonc.2021.735820] [Reference Citation Analysis]
3 Mäkelä R, Arjonen A, Suryo Rahmanto A, Härmä V, Lehtiö J, Kuopio T, Helleday T, Sangfelt O, Kononen J, Rantala JK. Ex vivo assessment of targeted therapies in a rare metastatic epithelial-myoepithelial carcinoma. Neoplasia 2020;22:390-8. [PMID: 32645560 DOI: 10.1016/j.neo.2020.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kakamad FH, Abdullah AM, Salih AM, Baba HO, Mohammed SH, Salih RQ, Abdulla BA, Hassan MN, Muhialdeen AS. Thymoma with osseous metaplasia; a case report with a brief literature review. Int J Surg Case Rep 2021;85:106149. [PMID: 34280875 DOI: 10.1016/j.ijscr.2021.106149] [Reference Citation Analysis]
5 Mäkelä R, Härmä V, Badra Fajardo N, Wells G, Lygerou Z, Sangfelt O, Kononen J, Rantala JK. Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma. Oncotarget 2021;12:1100-9. [PMID: 34084283 DOI: 10.18632/oncotarget.27961] [Reference Citation Analysis]
6 Mäkelä R, Arjonen A, Härmä V, Rintanen N, Paasonen L, Paprotka T, Rönsch K, Kuopio T, Kononen J, Rantala JK. Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma. BMC Cancer 2020;20:590. [PMID: 32576176 DOI: 10.1186/s12885-020-07092-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]